Efficacy News and Research

RSS
Meda's 2011 group net sales increase 18% to SEK 12,856 million

Meda's 2011 group net sales increase 18% to SEK 12,856 million

Adherence rates for hypertension medications lower among African-American patients

Adherence rates for hypertension medications lower among African-American patients

Nano-enabled intranasal formulation of teriparatide can treat osteoporosis

Nano-enabled intranasal formulation of teriparatide can treat osteoporosis

Corcept receives FDA approval for Korlym to treat endogenous Cushing's syndrome

Corcept receives FDA approval for Korlym to treat endogenous Cushing's syndrome

Innocoll completes XaraColl End-of-Phase 2 meeting with FDA

Innocoll completes XaraColl End-of-Phase 2 meeting with FDA

FDA approves Medtronic's Resolute Integrity DES to treat CAD

FDA approves Medtronic's Resolute Integrity DES to treat CAD

Digital games become an important tool for self-management of illness and chronic conditions

Digital games become an important tool for self-management of illness and chronic conditions

New UTA method shows promise against heart disease

New UTA method shows promise against heart disease

Epilepsy community concerned over AHRQ's AED drug comparison study

Epilepsy community concerned over AHRQ's AED drug comparison study

Acorda's fourth quarter GAAP net income increases to $12.7 million

Acorda's fourth quarter GAAP net income increases to $12.7 million

BioCryst fourth quarter revenues decrease to $5.2 million

BioCryst fourth quarter revenues decrease to $5.2 million

FDA approves preservative-free drug for glaucoma

FDA approves preservative-free drug for glaucoma

Moffitt receives patent for computerized system designed to improve clinical trial selection

Moffitt receives patent for computerized system designed to improve clinical trial selection

Aganirsen demonstrates significant activity in two models of wet AMD, ischemic retinopathy

Aganirsen demonstrates significant activity in two models of wet AMD, ischemic retinopathy

Agilent's microarrays used in landmark study on prenatal samples

Agilent's microarrays used in landmark study on prenatal samples

Diffusion opens enrollment for TSC clinical trial for newly diagnosed primary brain cancer

Diffusion opens enrollment for TSC clinical trial for newly diagnosed primary brain cancer

Merck's ZIOPTAN for reducing elevated IOP receives FDA approval

Merck's ZIOPTAN for reducing elevated IOP receives FDA approval

Trevena commences TRV130 Phase I clinical trial for severe post-operative pain

Trevena commences TRV130 Phase I clinical trial for severe post-operative pain

Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer

Tiltan initiates TL-118 Phase 2 clinical trial for pancreatic cancer

Regeneron reports total revenues of $123.0M for fourth quarter 2011

Regeneron reports total revenues of $123.0M for fourth quarter 2011

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.